Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2023 Filed Feb 2, 2023 20:40 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 13,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-002358 · rdgdoc.xml · nonDerivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 20:40 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-002358 · rdgdoc.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:05 UTC |
Kim DongChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 38,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001437749-23-002340 · rdgdoc.xml · derivative · entry 2 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Ordinary Shares · 38,000 shares Expires 2033-01-31 F3 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:05 UTC |
Kim DongChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002340 · rdgdoc.xml · derivative · entry 1 Kim Dong · CIK 0001920163 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F2 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. F2 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:04 UTC |
Smith Jason DrewGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001437749-23-002338 · rdgdoc.xml · derivative · entry 8 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Ordinary Shares · 40,000 shares Expires 2033-01-31 F6 · derivative.exercise_date: 1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:04 UTC |
Smith Jason DrewGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002338 · rdgdoc.xml · derivative · entry 7 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F5 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. F5 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:04 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002338 · rdgdoc.xml · derivative · entry 6 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Ordinary Shares · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. F4 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:04 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 833 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-002338 · rdgdoc.xml · derivative · entry 5 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 834 Underlying: Ordinary Shares · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:04 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 1,227 | $10.12 | $12,417.24 |
DisclosureSEC source: 0001437749-23-002338 · rdgdoc.xml · nonDerivative · entry 4 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,873 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:04 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-002338 · rdgdoc.xml · nonDerivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:04 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 409 | $10.12 | $4,139.08 |
DisclosureSEC source: 0001437749-23-002338 · rdgdoc.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,600 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:04 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-002338 · rdgdoc.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 00:10 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 122,677 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-23-001625 · rdgdoc.xml · derivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 122,677 shares Expires 2023-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 00:10 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 122,677 | $5.00 | $613,385.00 |
DisclosureSEC source: 0001437749-23-001625 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 22:57 UTC |
Wildman Daniel GeorgeDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $11.88 | $0.00 |
DisclosureSEC source: 0001437749-22-026635 · rdgdoc.xml · derivative · entry 1 Wildman Daniel George · CIK 0001952679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2032-11-08 F1 · derivative.exercise_date: The shares underlying the stock option vest in equal quarterly installments for 12 quarters Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 20:31 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-025549 · rdgdoc.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Ordinary Shares · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 20:31 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 258 | $11.85 | $3,057.30 |
DisclosureSEC source: 0001437749-22-025549 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,950 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| October 31, 2022 Filed Nov 2, 2022 20:31 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-025549 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 20:57 UTC |
Nussbaum RanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,276 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001437749-22-024711 · rdgdoc.xml · derivative · entry 3 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax Cayman III Limited Partnership Disclosed balance after: 0 Underlying: Ordinary Shares · 15,276 shares Expires 2022-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 20:57 UTC |
Nussbaum RanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 32,723 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001437749-22-024711 · rdgdoc.xml · derivative · entry 2 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax (Israel) III Limited Partnership Disclosed balance after: 0 Underlying: Ordinary Shares · 32,723 shares Expires 2022-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 20:57 UTC |
Nussbaum RanDirector
|
Exercise / conversionOrdinary Shares | 47,999 | $5.94 | $285,114.06 |
DisclosureSEC source: 0001437749-22-024711 · rdgdoc.xml · nonDerivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd Disclosed balance after: 1,481,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2022 Filed Feb 28, 2023 17:23 UTC Amendment |
Nussbaum RanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,276 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001437749-23-004868 · rdgdoc.xml · derivative · entry 3 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax Cayman III Limited Partnership Disclosed balance after: 0 Underlying: Ordinary Shares · 15,276 shares Expires 2022-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2022 Filed Feb 28, 2023 17:23 UTC Amendment |
Nussbaum RanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 32,723 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001437749-23-004868 · rdgdoc.xml · derivative · entry 2 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax (Israel) III Limited Partnership Disclosed balance after: 0 Underlying: Ordinary Shares · 32,723 shares Expires 2022-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2022 Filed Feb 28, 2023 17:23 UTC Amendment |
Nussbaum RanDirector
|
Exercise / conversionOrdinary Shares | 47,999 | $5.94 | $285,114.06 |
DisclosureSEC source: 0001437749-23-004868 · rdgdoc.xml · nonDerivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd Disclosed balance after: 1,485,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On October 25, 2022, the reporting person filed a Form 4 that inadvertently reported 1,481,927 shares of securities beneficially owned following reported transaction instead of 1,485,168 shares. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 19:13 UTC |
Belldegrun ArieDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 160,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-22-022616 · rdgdoc.xml · derivative · entry 2 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 160,000 shares Expires 2022-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 19:13 UTC |
Belldegrun ArieDirector
|
Exercise / conversionOrdinary Shares | 160,000 | $5.00 | $800,000.00 |
DisclosureSEC source: 0001437749-22-022616 · rdgdoc.xml · nonDerivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 12:28 UTC |
WEN LEANADirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.73 | $0.00 |
DisclosureSEC source: 0001437749-22-022162 · rdgdoc.xml · derivative · entry 1 WEN LEANA · CIK 0001847598 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2032-09-08 F1 · derivative.exercise_date: The shares underlying the stock option vest in equal quarterly installments for 12 quarters Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 15:40 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021776 · rdgdoc.xml · derivative · entry 3 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,334 Underlying: Ordinary Shares · 8,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vest in three equal annual installments on November 30, 2021, August 31, 2022 and August 31, 2023. F3 · derivative.expiration_date: The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vest in three equal annual installments on November 30, 2021, August 31, 2022 and August 31, 2023. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 15:40 UTC |
Smith Jason DrewGeneral Counsel
|
SaleOrdinary Shares | 3,606 | $7.21 | $25,999.26 |
DisclosureSEC source: 0001437749-22-021776 · rdgdoc.xml · nonDerivative · entry 2 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,176 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 15:40 UTC |
Smith Jason DrewGeneral Counsel
|
Exercise / conversionOrdinary Shares | 8,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-021776 · rdgdoc.xml · nonDerivative · entry 1 Smith Jason Drew · CIK 0001821479 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 15:40 UTC |
Belldegrun ArieDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,241 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021777 · rdgdoc.xml · derivative · entry 2 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,241 shares Expires 2022-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 15:40 UTC |
Belldegrun ArieDirector
|
Exercise / conversionOrdinary Shares | 3,241 | $5.00 | $16,205.00 |
DisclosureSEC source: 0001437749-22-021777 · rdgdoc.xml · nonDerivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 25, 2022 19:25 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 259 | $7.81 | $2,022.79 |
DisclosureSEC source: 0001437749-22-021337 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,708 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| July 31, 2022 Filed Aug 25, 2022 19:25 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021337 · rdgdoc.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Ordinary Shares · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| July 31, 2022 Filed Aug 25, 2022 19:25 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-021337 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
| June 16, 2022 Filed Feb 28, 2023 17:21 UTC |
Nussbaum RanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,211 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004866 · rdgdoc.xml · derivative · entry 2 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax (Israel) III Limited Partnership Disclosed balance after: 0 Underlying: Ordinary Shares · 2,211 shares Expires 2022-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2022 Filed Feb 28, 2023 17:21 UTC |
Nussbaum RanDirector
|
Exercise / conversionOrdinary Shares | 2,211 | $5.00 | $11,055.00 |
DisclosureSEC source: 0001437749-23-004866 · rdgdoc.xml · nonDerivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd. Disclosed balance after: 1,437,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 15:36 UTC |
Holden StuartDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001437749-22-014771 · rdgdoc.xml · derivative · entry 1 Holden Stuart · CIK 0001763999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 19:37 UTC |
Belldegrun ArieDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001437749-22-014774 · rdgdoc.xml · derivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 19:37 UTC |
Cohen Fred EDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001437749-22-014772 · rdgdoc.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 19:37 UTC |
BUTITTA CYNTHIA MDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001437749-22-014773 · rdgdoc.xml · derivative · entry 1 BUTITTA CYNTHIA M · CIK 0001222082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 19:36 UTC |
Nussbaum RanDirector
|
GrantStock Option (right to buy) · Derivative | 3,183 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001437749-22-014770 · rdgdoc.xml · derivative · entry 2 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax Cayman III Limited Partnership Disclosed balance after: 3,183 Underlying: Ordinary Shares · 3,183 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 19:36 UTC |
Nussbaum RanDirector
|
GrantStock Option (right to buy) · Derivative | 6,817 | $0.00 Strike: $7.06 | $0.00 |
DisclosureSEC source: 0001437749-22-014770 · rdgdoc.xml · derivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Pontifax (Israel) III Limited Partnership Disclosed balance after: 6,817 Underlying: Ordinary Shares · 6,817 shares Expires 2032-06-08 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 06, 2022 Filed Aug 25, 2022 19:25 UTC |
Nussbaum RanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,030 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021338 · rdgdoc.xml · derivative · entry 2 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax Cayman III Limited Partnership Disclosed balance after: 0 Underlying: Ordinary Shares · 1,030 shares Expires 2022-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Aug 25, 2022 19:25 UTC |
Nussbaum RanDirector
|
Exercise / conversionOrdinary Shares | 1,030 | $5.00 | $5,150.00 |
DisclosureSEC source: 0001437749-22-021338 · rdgdoc.xml · nonDerivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd. Disclosed balance after: 1,433,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2022 Filed Feb 28, 2023 17:29 UTC Amendment |
Nussbaum RanDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,030 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004870 · rdgdoc.xml · derivative · entry 2 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Pontifax Cayman III Limited Partnership Disclosed balance after: 0 Underlying: Ordinary Shares · 1,030 shares Expires 2022-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: On August 25, 2022, the reporting person filed a Form 4 that inadvertently list the expiration date as August 31, 2022. Read SEC document |
| June 06, 2022 Filed Feb 28, 2023 17:29 UTC Amendment |
Nussbaum RanDirector
|
Exercise / conversionOrdinary Shares | 1,030 | $5.00 | $5,150.00 |
DisclosureSEC source: 0001437749-23-004870 · rdgdoc.xml · nonDerivative · entry 1 Nussbaum Ran · CIK 0001609805 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd. Disclosed balance after: 1,434,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On August 25, 2022, the reporting person filed a Form 4 that inadvertently reported 1,433,928 shares of securities beneficially owned following reported transaction instead of 1,434,958 shares. Read SEC document |
| April 30, 2022 Filed May 3, 2022 21:19 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-010701 · rdgdoc.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Ordinary Shares · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| April 30, 2022 Filed May 3, 2022 21:19 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 254 | $6.62 | $1,681.48 |
DisclosureSEC source: 0001437749-22-010701 · rdgdoc.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,467 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| April 30, 2022 Filed May 3, 2022 21:19 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-010701 · rdgdoc.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.